Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2685939 | 0.83 | CXCR4 (0.69) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL30862011 | 0.80 | KDM4E (0.72) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL13090580 | 0.80 | KDM4E (0.72) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL12674819 | 0.80 | KDM4E (0.57) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| Msx-122 SCHEMBL10054965 | 0.80 | CXCR4 (0.61) | KDM4EALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL29995846 | 0.79 | GAA (0.56) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL12675588 | 0.79 | GAA (0.56) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL9279836 | 0.78 | GAA (0.63) | GAAKDM4EMAPTL3MBTL1ALDH1A1 | |
| SCHEMBL1883338 | 0.76 | CYP3A4 (0.57) | GAAKDM4EMAPTL3MBTL1 | |
| SCHEMBL12675581 | 0.76 | GAA (0.61) | GAAKDM4EMAPTL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3383874-A1 | MESOIONIC HALOGENATED 3-(ACETYL)-1-[(1,3-THIAZOL-5-YL)METHYL]-1H-IMIDAZO[1,2-A]PYRIDIN-4-IUM-2-OLATE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2018-10-10 | — | — | EP | disclosed |
| US-20180282323-A1 | Mesoionic imidazole derivatives as insecticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-10-04 | — | — | US | disclosed |
| WO-2017093214-A1 | MESOIONIC HALOGENATED 3-(ACETYL)-1-[(1,3-THIAZOL-5-YL)METHYL]-1H-IMIDAZO[1,2-A]PYRIDIN-4-IUM-2-OLATE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180282323-A1 | Mesoionic imidazole derivatives as insecticides | CHRM1, DDT, CHRM2 | GAA 1262/4885KDM4E 1566/4885MAPT 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.